Clinical Read2026-06-01

Ampligen (rintatolimod) with Imfinzi (durvalumab) - (DURIPANC)

AIM ImmunoTech Inc.AIM
Indication
Pancreatic Cancer
Stage
phase2
Event
Phase 2